Uni-Bio Science Group Ltd ($690) - buy or sell? Stock discussion, ideas, forum

Uni-Bio Science Group Ltd

Uni-Bio Science Group Limited is a bio-science related business with focus on the research, development and commercialization of biopharmaceuticals through recombinant DNA and other technologies.

Industry: Biotechnology

Ticker	Exchange	ISIN	Name
$690	HKEx Main Board	KYG9198H1406	Code: 690

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 690 stock

Share your investment idea or question on Uni-Bio Science Group Ltd stock:

Latest twits on Uni-Bio Science Group Ltd (690)

No twits yet. Be the first to post!

Have a question about 690? Ask and other investors will be eager to help you.

Have an idea about 690? Share it with other investors.

Uni-Bio Science Group Ltd news

27/03/2017 Uni-Bio Science Group Ltd reports 18.7% revenue growth in FY2016

13/06/2016 Uni-Bio Science Group Ltd CAPEX dropped on 48.4% in 2015 while Revenue surged on 20.2%

Uni-Bio Science Group Ltd stock price chart

Uni-Bio Science Group Ltd financials

mln. HKD	FY2010	FY2011	FY2012

Revenue	148.3	76.764	57.026
EBITDA	-30.750	-6.144	-14.404
Net income	-454.653	-185.156	-102.864
CAPEX	1.003	3.932	13.644
Debt	32.075	23.766	87.270
Cash	62.943	16.545	22.273

Uni-Bio Science Group Ltd news

27/03/2017 Uni-Bio Science Group Ltd reports 18.7% revenue growth in FY2016

13/06/2016 Uni-Bio Science Group Ltd CAPEX dropped on 48.4% in 2015 while Revenue surged on 20.2%

About Uni-Bio Science Group Ltd

Uni-Bio Science Group Limited is a bio-science related business with focus on the research, development and commercialization of biopharmaceuticals through recombinant DNA and other technologies.